Specialized Program of Research Excellence (SPORE)
Topics in This Section
Women's Cancer Center
The Resource and Education Center
Find a Clinical Trial
Benefit from new cancer treatments
Read more »
My Fox Chase Experience
Making a Difference
As survivors of ovarian cancer, April Donahue and Karen Mason wanted to make a difference on the future of cancer research. Find out how Fox Chase scientists took them up on their offer.
Awarded to Fox Chase for Ovarian Cancer Research
The National Cancer Institute (NCI) awards prestigious grants for Specialized Programs of Research Excellence (SPORE) in prevention, diagnosis and treatment of ovarian cancer. Fox Chase Cancer Center is one of the premier cancer centers nationwide to receive a SPORE grant focusing on ovarian cancer research.
Through the SPORE grant, Fox Chase carries out innovative, multidisciplinary research for ovarian cancer that may have an immediate impact on improving care and prevention of this disease.
Funding Translational Research
Translational research is fundamental in developing new treatments for cancer patients. It involves taking basic research findings from the laboratory into patient care settings. The goal of this particular "translational" research funded by our SPORE grant is to find methods of early detection of ovarian cancer. This research also focuses on improving ovarian cancer prevention and treatment options.
Jeff Boyd, PhD, is the principal investigator of the SPORE grant at Fox Chase Cancer Center. Robert Burger, MD, from the University of Pennsylvania is co-principal investigator on this grant.
Learn more about specific SPORE projects at Fox Chase Cancer Center.
Partnering with Patients
Patient advocates join the ovarian cancer research team at Fox Chase Cancer Center.
For more information about gynecological cancer treatment and prevention at Fox Chase Cancer Center or to make an appointment, call 1-888-FOX CHASE (1-888-369-2427).